Shop

Retatrutide

Retatrutide is a synthetic triple agonist peptide that interacts with GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This triple pathway activity has made it one of the most studied peptides in the field of metabolic research. By acting on multiple hormonal systems, retatrutide builds on mechanisms previously investigated in incretin-based compounds, such as semaglutide (GLP-1 only) and tirzepatide (GLP-1 + GIP).

Researchers are exploring its effects on appetite regulation, glucose metabolism, fat oxidation, and energy expenditure, and early findings suggest improved results compared to single and dual agonist peptides.

Mechanisms of Action (under investigation)

GLP-1 receptor agonism: Its role in delaying gastric emptying, regulating appetite signals, and modulating insulin release has been studied.

GIP receptor agonism: Its role in supporting insulin sensitivity, glucose tolerance, and lipid metabolism has been investigated.

Glucagon receptor agonism: Its role in increasing energy expenditure and promoting lipolysis is being investigated.

Research Results

Clinical studies have compared retatrutide with other incretin-based peptides:

Semaglutide (GLP-1 only): Average weight reduction of approximately 17% after 68 weeks.

Tirzepatide (GLP-1 + GIP): Average weight reduction of approximately 24.7% after 72 weeks.

Retatrutide (GLP-1 + GIP + glucagon):

Approximately 17.5% weight loss at 24 weeks

Approximately 26.2% weight loss at 48 weeks

These findings suggest that retatrutide may act more rapidly and achieve substantial body weight reduction in shorter periods of time.

Additional Areas of Research

Scientists are investigating the role of retatrutide in several areas of study, including:

Inflammation: Preclinical studies suggest potential anti-inflammatory activity.

Collagen synthesis and epithelialization: Its role in tissue and skin health is being explored.

Wound healing and angiogenesis: Its effects on tissue regeneration and vascular development are being studied.

Muscle biology: Preliminary research on satellite cell activation and muscle recovery.

Emerging Applications (Exploratory Research)

In addition to metabolic studies, retatrutide is being investigated for its potential roles in:

Cardiovascular health (risk markers such as vascular inflammation and lipid balance)

Liver function (including non-alcoholic fatty liver disease, NAFLD)

Neurological disorders (Alzheimer's, Parkinson's, and other degenerative diseases)

Sleep and behavior (research on sleep apnea, cravings, and mood regulation)

(30-day supply kit)